Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 13, 2017

View Archived Issues

DS-28120313 shows in vivo efficacy as a potent orally active hepcidin production inhibitor

Immunocore's IMCgp-100 and ProMetic Life Sciences' PBI-4050 awarded UK PIM designation

Bayer identifies novel AKR1C3 inhibitors

BioStem Technologies, University of Miami to conduct preclinical study of BSEM17-115

Cyclenium Pharma and Ono enter drug discovery collaboration agreement

FDA approves Nucala for the treatment of eosinophilic granulomatosis with polyangiitis

Mersana Therapeutics doses first patient in phase I study of XMT-1536

First phase I data reported for GDC-0927 in breast cancer

Aduro BioTech discontinuing development of CRS-207

A novel hypoxia-activated FLT3 inhibitor prodrug shows activity in FLT3-mutated AML

First patient randomized in phase II study of rifamycin SV in IBS-D

FDA lifts clinical hold on PTX-200 breast cancer trial

NorthSea Therapeutics secures funding to develop icosabutate for the treatment of NASH

Mallinckrodt's acquisition of Ocera Therapeutics completed

Indication for Omidria expanded in U.S.

Aprecia partners with Cycle Pharmaceuticals to develop 3D-printed orphan drugs

Alnylam Pharmaceuticals completes rolling NDA submission for patisiran

Evotec establishes retinal disease research collaboration with CRTD

Researchers develop a new U2af1-knockout mouse model of MDS

European Commission grants orphan drug designation to KL-1333 for MELAS

Akarna Therapeutics presents novel BAR agonists

Hangzhou Innogate Pharma patents FGFR4 inhibitors

Biomarker panel links inflammatory proteins to epilepsy

Novel TLR8 agonists presented by Roche

First patient dosed in PROSTAR combination study of CPI-1205

Tonix Pharmaceuticals planning to file IND for TNX-102 SL

EMA's CHMP requests additional information for betrixaban MAA

Ducentis Biotherapeutics patents mutant polypeptides for autoimmune disorders

FDA extends action date for review of Xeljanz sNDA in ulcerative colitis

Daiichi Sankyo and Puma announce research collaboration with Memorial Sloan Kettering

Topline pivotal results reported for cemiplimab in advanced cutaneous squamous cell carcinoma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...